BioLineRx (BLRX) Share-based Compensation (2014 - 2026)
BioLineRx (BLRX) posted Share-based Compensation of $79,000 for the quarter ended Jun 30, 2026, up 49.1% from $53,000 a year earlier and up 1.3% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Share-based Compensation (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at BioLineRx was $306,000, down 25.7% year-over-year; for the year ended Dec 31, 2025, it came in at $396,000, down 65.1% from the prior year.
- Annual Share-based Compensation shows a five-year compound annual growth rate of -20.8% (years ended Dec 2020 to Dec 2025).
- In prior years, BioLineRx's Share-based Compensation was $1.14 million in the year ended Dec 31, 2024 (-51.1%), $2.32 million in the year ended Dec 31, 2023 (+3.4%), $2.25 million in the year ended Dec 31, 2022 (+50.2%) and $1.5 million in the year ended Dec 31, 2021 (+17.5%).
- Quarterly Share-based Compensation has run from a low of -$154,000 in the quarter ended Dec 31, 2024 to a high of $1.05 million in the quarter ended Dec 31, 2022 over five years.
- On a year-over-year basis, Share-based Compensation increased in 1 of the last six quarters, with an average decline of 43.8%.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was the quarter ended Dec 31, 2022, with growth of 167.3%; the weakest was the quarter ended Jun 30, 2025, with a decline of 87.9%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $78,000 (quarter ended Mar 31, 2026), $48,000 (quarter ended Dec 31, 2025) and $101,000 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | BioLineRx | 6.34 Bn | 6.35 Bn | 235,000.00 | 79,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79,000.00 |
| Mar 31, 2026 | 78,000.00 |
| Dec 31, 2025 | 48,000.00 |
| Sep 30, 2025 | 101,000.00 |
| Jun 30, 2025 | 53,000.00 |
| Mar 31, 2025 | 194,000.00 |
| Dec 31, 2024 | -154,000.00 |
| Sep 30, 2024 | 319,000.00 |
| Jun 30, 2024 | 437,000.00 |
| Mar 31, 2024 | 533,000.00 |
| Dec 31, 2023 | 929,000.00 |
| Sep 30, 2023 | 472,000.00 |
| Jun 30, 2023 | 485,000.00 |
| Mar 31, 2023 | 435,000.00 |
| Dec 31, 2022 | 1.05 Mn |
| Sep 30, 2022 | 614,000.00 |
| Jun 30, 2022 | 330,000.00 |
| Mar 31, 2022 | 256,000.00 |
| Dec 31, 2021 | 391,000.00 |
| Sep 30, 2021 | 272,000.00 |
API Access
BioLineRx Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();